Published date: 1 December 2020

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 1 September 2020, 12am

Contract summary

Industry

  • Pharmaceutical products - 33600000

  • Various medicinal products - 33690000

Location of contract

England

Value of contract

£0 to £75,000,000

Procurement reference

CF-0075100D0O000000rwimUAA1

Published date

1 December 2020

Closing date

1 September 2020

Closing time

12am

Contract start date

1 December 2020

Contract end date

30 November 2022

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

NHS Framework for the supply of drugs licensed specifically to target epidermal growth factor receptor (EGFR)-expressing, RAS wild-type metastatic colorectal cancer

Award information

Awarded date

13 November 2020

Contract start date

1 December 2020

Contract end date

30 November 2022

Total value of contract

£75,000,000

This contract was awarded to 2 suppliers.

Amgen Ltd

Address

240 Science Park, Cambridge, CB4 0WD

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

Merck Serono Limited

Address

5 New Square, Bedfont Lakes Business Park,, Feltham, TW14 8HA

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Contact name

Liz Fleetwood

Address

Rutland House
Runcorn
WA7 2ES
GB

Email

liz.fleetwood1@nhs.net